Status:
COMPLETED
Diaphragmatic Ultrasound and Thoracic Fluid Content for Prediction of Non-Invasive Ventilation Failure in Neonates
Lead Sponsor:
Lamiaa Khaled Zidan
Conditions:
Diaphragm Ultrasound
Electrical Cardiometry
Eligibility:
All Genders
30-30 years
Brief Summary
This research assessed diaphragmatic ultrasound and thoracic fluid content (TFC) as potential early predictive tools for detecting NIV failure in preterm neonates.
Detailed Description
Non-invasive ventilatory support (NIV) is considered a gold standard care for preterm infants with respiratory distress syndrome (RDS); however, NIV failure remains a frequent challenge that is often ...
Eligibility Criteria
Inclusion
- Preterm neonates of both sexes, with gestational ages ranging from 28 to 34 weeks, diagnosed with RDS and requiring non-invasive ventilation within 30 minutes of birth
Exclusion
- Exclusion criteria included intubation in the delivery room, complex congenital heart disease, major congenital anomalies in the lungs or airways, and other causes of respiratory distress unrelated to RDS.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07148102
Start Date
May 1 2020
End Date
May 1 2023
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Tanta University
Tanta, Tanta, Q2x2+cp Tanta 2, Egypt, Egypt, 31527